Khoja et al., using the CellSearch® system, performed sequential testing of melanoma patients treated with dacarbazine, BRAF, and MEK inhibitors, or immunotherapy with a CTLA-4 monoclonal antibody. The gene discussed is MAP2K7; the disease is melanoma.